首页 > 最新文献

Integrative Medicine Research最新文献

英文 中文
Real-world data analysis on effectiveness of integrative therapies: A practical guide to study design and data analysis using healthcare databases 关于综合疗法有效性的真实世界数据分析:使用医疗保健数据库进行研究设计和数据分析的实用指南
IF 3.4 4区 医学 Q1 Medicine Pub Date : 2023-10-20 DOI: 10.1016/j.imr.2023.101000
Ye-Seul Lee, Yoon Jae Lee, In-Hyuk Ha

Real world data (RWD) is increasingly used to investigate health outcomes and treatment efficacy in the field of integrative medicine. Due to the fact that the majority of RWDs are not intended for research, their secondary use in research necessitates complex study designs to account for bias and confounding. To conduct a robust analysis of RWD in integrative medicine, a comprehensive study design process that reflects the characteristics of integrative therapies is necessary. In this paper, we present a guide for designing comparative effectiveness RWE research in integrative medicine. We discuss key factors to consider when selecting RWDs for research on integrative medicine. We provide practical steps for developing a research question, formulating the PICOT objectives (population, intervention, comparator, outcome, and time horizon), and selecting and defining covariates with a summary table. Specific study designs are depicted with corresponding diagrams. Finally, data analysis procedures are introduced. We hope this article clarifies the importance of RWE research design and related processes in order to improve the rigor of RWD studies in the field of integrative medicine research.

现实世界数据(RWD)越来越多地用于调查健康结果和治疗效果在中西医结合领域。由于大多数rwd不是用于研究,它们在研究中的二次使用需要复杂的研究设计,以考虑偏差和混淆。为了对中西医结合中的RWD进行强有力的分析,一个反映中西医结合治疗特点的综合研究设计过程是必要的。在本文中,我们提出了一个指南,设计比较有效的RWE研究在中西医结合。我们讨论了在选择中西医结合研究的rwd时要考虑的关键因素。我们提供了开发研究问题、制定PICOT目标(人群、干预、比较者、结果和时间范围)以及使用汇总表选择和定义协变量的实际步骤。具体的研究设计用相应的图表来描述。最后介绍了数据分析过程。我们希望本文能阐明RWE研究设计及相关流程的重要性,以提高RWD研究在中西医结合研究领域的严谨性。
{"title":"Real-world data analysis on effectiveness of integrative therapies: A practical guide to study design and data analysis using healthcare databases","authors":"Ye-Seul Lee,&nbsp;Yoon Jae Lee,&nbsp;In-Hyuk Ha","doi":"10.1016/j.imr.2023.101000","DOIUrl":"https://doi.org/10.1016/j.imr.2023.101000","url":null,"abstract":"<div><p>Real world data (RWD) is increasingly used to investigate health outcomes and treatment efficacy in the field of integrative medicine. Due to the fact that the majority of RWDs are not intended for research, their secondary use in research necessitates complex study designs to account for bias and confounding. To conduct a robust analysis of RWD in integrative medicine, a comprehensive study design process that reflects the characteristics of integrative therapies is necessary. In this paper, we present a guide for designing comparative effectiveness RWE research in integrative medicine. We discuss key factors to consider when selecting RWDs for research on integrative medicine. We provide practical steps for developing a research question, formulating the PICOT objectives (population, intervention, comparator, outcome, and time horizon), and selecting and defining covariates with a summary table. Specific study designs are depicted with corresponding diagrams. Finally, data analysis procedures are introduced. We hope this article clarifies the importance of RWE research design and related processes in order to improve the rigor of RWD studies in the field of integrative medicine research.</p></div>","PeriodicalId":13644,"journal":{"name":"Integrative Medicine Research","volume":null,"pages":null},"PeriodicalIF":3.4,"publicationDate":"2023-10-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2213422023000793/pdfft?md5=89c1006144dfc63a4bf6a0117602b214&pid=1-s2.0-S2213422023000793-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90029701","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Saposhnikovia divaricata root and its major components ameliorate inflammation and altered gut microbial diversity and compositions in DSS-induced colitis 菝葜根及其主要成分可改善dss诱导的结肠炎的炎症和改变肠道微生物的多样性和组成
IF 3.4 4区 医学 Q1 Medicine Pub Date : 2023-10-19 DOI: 10.1016/j.imr.2023.100998
Saruul Erdenebileg , Yang-Ju Son , Myungsuk Kim , Sarangerel Oidovsambuu , Kwang Hyun Cha , Jaeyoung Kwon , Da Seul Jung , Chu Won Nho

Background

The root of Saposhnikovia divaricata (Turcz.) Schischk is a well-known traditional medicinal plant, containing various bioactive compounds with anti-inflammatory, antioxidant, and analgesic properties. However, no scientific studies have validated its clinical use as an anti-inflammatory agent against inflammatory bowel disease (IBD). This study aimed to investigate whether the root extract of S. divaricata ameliorates IBD and induces gut microbial alteration, using a RAW 264.7 cell line and a DSS-induced colitis mouse model.

Methods

To investigate the anti-inflammatory effects and alleviation of IBD, using a methanol extract of Saposhnikovia divaricata (Turcz.) Schischk. root (MESD), RAW 264.7, murine macrophages and a dextran sodium sulfate (DSS)-induced colitis mouse model were employed. 16S rRNA gene sequencing was conducted to determine the alterations in the gut microbiota of mice with DSS-induced colitis.

Results

MESD significantly decreased nitric oxide (NO) and inflammatory cytokine levels in lipopolysaccharide (LPS)-induced RAW 264.7 cells in vitro. Oral administration of MESD reduced the expression of inflammatory cytokines in the colons of mice with DSS-induced colitis. Additionally, MESD inhibited the abundance of Clostridium sensu stricto 1 and enhanced the predicted functional pathways, including l-glutamate degradation VIII (to propanoic acid). Seven compounds with anti-inflammatory properties were isolated from the MESD. Among them, 3′-O-acetylhamaudol and 3′-O-angeloylhamaudol exhibited strong anti-inflammatory effects in vitro.

Conclusion

Overall, MESD may be a potential natural product for the treatment of IBD by lowering inflammatory cytokine levels and altering gut microbiota composition.

背景:土属植物Saposhnikovia divaricata石竹是一种著名的传统药用植物,含有多种生物活性化合物,具有抗炎、抗氧化、镇痛等作用。然而,没有科学研究证实其作为抗炎症性肠病(IBD)的抗炎剂的临床应用。本研究旨在通过RAW 264.7细胞系和dss诱导的结肠炎小鼠模型,研究鸢尾根提取物是否能改善IBD并诱导肠道微生物改变。方法采用甲醇提取物对IBD的抗炎和缓解作用进行研究。Schischk。采用小鼠巨噬细胞和右旋糖酐硫酸钠(DSS)诱导的小鼠结肠炎模型。通过16S rRNA基因测序来确定dss诱导结肠炎小鼠肠道菌群的变化。结果smesd显著降低脂多糖(LPS)诱导的RAW 264.7细胞的一氧化氮(NO)和炎性细胞因子水平。口服MESD可降低dss诱导结肠炎小鼠结肠中炎症细胞因子的表达。此外,MESD抑制了严格感梭菌1的丰度,并增强了预测的功能途径,包括l-谷氨酸降解VIII(到丙酸)。从MESD中分离到7个具有抗炎作用的化合物。其中,3′- o -乙酰哈马多尔和3′- o - angeloyl哈马多尔在体外表现出较强的抗炎作用。综上所述,MESD可能是通过降低炎症细胞因子水平和改变肠道菌群组成来治疗IBD的潜在天然产物。
{"title":"Saposhnikovia divaricata root and its major components ameliorate inflammation and altered gut microbial diversity and compositions in DSS-induced colitis","authors":"Saruul Erdenebileg ,&nbsp;Yang-Ju Son ,&nbsp;Myungsuk Kim ,&nbsp;Sarangerel Oidovsambuu ,&nbsp;Kwang Hyun Cha ,&nbsp;Jaeyoung Kwon ,&nbsp;Da Seul Jung ,&nbsp;Chu Won Nho","doi":"10.1016/j.imr.2023.100998","DOIUrl":"https://doi.org/10.1016/j.imr.2023.100998","url":null,"abstract":"<div><h3>Background</h3><p>The root of <em>Saposhnikovia divaricata</em> (Turcz.) Schischk is a well-known traditional medicinal plant, containing various bioactive compounds with anti-inflammatory, antioxidant, and analgesic properties. However, no scientific studies have validated its clinical use as an anti-inflammatory agent against inflammatory bowel disease (IBD). This study aimed to investigate whether the root extract of <em>S. divaricata</em> ameliorates IBD and induces gut microbial alteration, using a RAW 264.7 cell line and a DSS-induced colitis mouse model.</p></div><div><h3>Methods</h3><p>To investigate the anti-inflammatory effects and alleviation of IBD, using a methanol extract of <em>Saposhnikovia divaricata</em> (Turcz.) Schischk. root (MESD), RAW 264.7, murine macrophages and a dextran sodium sulfate (DSS)-induced colitis mouse model were employed. 16S rRNA gene sequencing was conducted to determine the alterations in the gut microbiota of mice with DSS-induced colitis.</p></div><div><h3>Results</h3><p>MESD significantly decreased nitric oxide (NO) and inflammatory cytokine levels in lipopolysaccharide (LPS)-induced RAW 264.7 cells <em>in vitro</em>. Oral administration of MESD reduced the expression of inflammatory cytokines in the colons of mice with DSS-induced colitis. Additionally, MESD inhibited the abundance of <em>Clostridium sensu stricto</em> 1 and enhanced the predicted functional pathways, including <span>l</span>-glutamate degradation VIII (to propanoic acid). Seven compounds with anti-inflammatory properties were isolated from the MESD. Among them, 3′-O-acetylhamaudol and 3′-O-angeloylhamaudol exhibited strong anti-inflammatory effects <em>in vitro</em>.</p></div><div><h3>Conclusion</h3><p>Overall, MESD may be a potential natural product for the treatment of IBD by lowering inflammatory cytokine levels and altering gut microbiota composition.</p></div>","PeriodicalId":13644,"journal":{"name":"Integrative Medicine Research","volume":null,"pages":null},"PeriodicalIF":3.4,"publicationDate":"2023-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S221342202300077X/pdfft?md5=defe800f4db3bce02c67d4b4f5ab6743&pid=1-s2.0-S221342202300077X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"92100321","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acupuncture for ventilator-dependent patients at a hospital-based respiratory care center: A randomized controlled trial 针刺治疗医院呼吸护理中心呼吸机依赖患者:一项随机对照试验
IF 3.4 4区 医学 Q1 Medicine Pub Date : 2023-10-17 DOI: 10.1016/j.imr.2023.100997
Jia-Ming Chen , Wan-Li Chiang , Bin-Chuan Ji , Ruei-Jhe Jhang , Pei-Hsin Chen , Ya-Lun Li , Che-Ju Chang , Sung-Yen Huang , Tsung-Chieh Lee , Chia-Yun Chen , Ching-Hsiung Lin , Sheng-Hao Lin

Background

In intensive care units, mechanical ventilation is an important therapy to help patients with dyspnea. However, long-term ventilator dependence would consume huge medical resources and increase the risk of morbidity and mortality. The aim of the study was to examine the efficacy of the acupuncture combined with western medical care on ventilator parameters in ventilator-dependent patients.

Methods

In this clinical trial, 80 ventilator-dependent patients aged 20 to 80 years old were randomly assigned to acupuncture group and control group in the respiratory care center (RCC) of Changhua Christian Hospital. Besides regular medical care and therapy, participants in the acupuncture group received acupuncture therapy at the same 17 acu-points for 20 minutes once a day, a total of 12 sessions. The ventilator parameters were recorded to evaluate the respiratory efficiency for all participants. The primary outcome was rapid shallow breathing index (RSBI), and secondary outcomes were respiratory rate (RR), tidal volume (TV) and ventilation per minute (MV),

Results

Though there was no significant difference in the parameter between the acupuncture group and the control group, we found the trend of decreasing RSBI in the acupuncture group. In subgroup analyses, the mean of RSBI significantly decreased 16.02 (with the SD in 60.84) in acupuncture group, while it increased 17.84 (with the SD in 39.38) in control group (p=0.036) after 12 sessions.

Conclusion

Acupuncture treatment can improve breathing ability of patients with respirator dependence in respiratory care center.

在重症监护病房,机械通气是帮助呼吸困难患者的重要治疗方法。然而,长期依赖呼吸机会消耗大量的医疗资源,增加发病和死亡的风险。本研究旨在探讨针刺结合西医护理对呼吸机依赖患者呼吸机参数的影响。方法将80例年龄在20 ~ 80岁的呼吸机依赖患者随机分为针刺组和对照组。除了常规的医疗护理和治疗外,针灸组的参与者还接受同样17个穴位的针灸治疗,每天一次,每次20分钟,共12次。记录呼吸机参数以评估所有参与者的呼吸效率。主要指标为快速浅呼吸指数(RSBI),次要指标为呼吸频率(RR)、潮气量(TV)、每分钟通气量(MV)。结果针刺组与对照组在各项指标上无显著差异,但针刺组有降低RSBI的趋势。在亚组分析中,针刺组12个疗程后RSBI均值显著降低16.02 (SD值为60.84),对照组显著升高17.84 (SD值为39.38),差异有统计学意义(p=0.036)。结论针刺治疗可改善呼吸机依赖患者的呼吸能力。
{"title":"Acupuncture for ventilator-dependent patients at a hospital-based respiratory care center: A randomized controlled trial","authors":"Jia-Ming Chen ,&nbsp;Wan-Li Chiang ,&nbsp;Bin-Chuan Ji ,&nbsp;Ruei-Jhe Jhang ,&nbsp;Pei-Hsin Chen ,&nbsp;Ya-Lun Li ,&nbsp;Che-Ju Chang ,&nbsp;Sung-Yen Huang ,&nbsp;Tsung-Chieh Lee ,&nbsp;Chia-Yun Chen ,&nbsp;Ching-Hsiung Lin ,&nbsp;Sheng-Hao Lin","doi":"10.1016/j.imr.2023.100997","DOIUrl":"https://doi.org/10.1016/j.imr.2023.100997","url":null,"abstract":"<div><h3>Background</h3><p>In intensive care units, mechanical ventilation is an important therapy to help patients with dyspnea. However, long-term ventilator dependence would consume huge medical resources and increase the risk of morbidity and mortality. The aim of the study was to examine the efficacy of the acupuncture combined with western medical care on ventilator parameters in ventilator-dependent patients.</p></div><div><h3>Methods</h3><p>In this clinical trial, 80 ventilator-dependent patients aged 20 to 80 years old were randomly assigned to acupuncture group and control group in the respiratory care center (RCC) of Changhua Christian Hospital. Besides regular medical care and therapy, participants in the acupuncture group received acupuncture therapy at the same 17 acu-points for 20 minutes once a day, a total of 12 sessions. The ventilator parameters were recorded to evaluate the respiratory efficiency for all participants. The primary outcome was rapid shallow breathing index (RSBI), and secondary outcomes were respiratory rate (RR), tidal volume (TV) and ventilation per minute (MV),</p></div><div><h3>Results</h3><p>Though there was no significant difference in the parameter between the acupuncture group and the control group, we found the trend of decreasing RSBI in the acupuncture group. In subgroup analyses, the mean of RSBI significantly decreased 16.02 (with the SD in 60.84) in acupuncture group, while it increased 17.84 (with the SD in 39.38) in control group (p=0.036) after 12 sessions.</p></div><div><h3>Conclusion</h3><p>Acupuncture treatment can improve breathing ability of patients with respirator dependence in respiratory care center.</p></div>","PeriodicalId":13644,"journal":{"name":"Integrative Medicine Research","volume":null,"pages":null},"PeriodicalIF":3.4,"publicationDate":"2023-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2213422023000768/pdfft?md5=371d4c2d4d36c5ec6fdb7be0ff12d3f0&pid=1-s2.0-S2213422023000768-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134656112","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dietary and herbal supplement consumer health information for pain: A cross-sectional survey and quality assessment of online content 膳食和草药补充剂消费者健康信息的疼痛:横断面调查和在线内容的质量评估
IF 3.4 4区 医学 Q1 Medicine Pub Date : 2023-09-28 DOI: 10.1016/j.imr.2023.100996
Jeremy Y Ng, Sahar Popal, Sathurthika Selvanayagam

Background

Patients are increasingly utilizing the internet to learn about dietary and herbal supplements (DHSs) for various diseases/conditions, including pain management. Online health information has been found to be inconsistent and of poor quality in prior studies, which may have detrimental effects on patient health. This study assessed the quality of online DHSs consumer health information for pain.

Methods

Six search items related to DHSs and pain were used to generate the first 20 websites on Google across four English-speaking countries. The identified 480 webpages produced 68 eligible websites, which were then evaluated using the DISCERN tool. The mean scores and standard deviations (SD) of the reviewers’ ratings on each of the 15 DISCERN instrument items as well as the overall total score were calculated.

Results

The mean summed score for the 68 eligible websites was 46.6 (SD = 10.1), and the mean overall rating was 3.3 (SD = 0.8). Websites lacked information regarding areas of uncertainty, the effects of no treatment being used, and how treatments affect the overall quality of life. These shortcomings were especially apparent across commercial websites, which frequently displayed bias, failed to report the risks of DHS products, and lacked support for shared decision-making regarding the use of DHSs.

Conclusion

Variability exists in the quality of online consumer health information regarding DHS use for pain. Healthcare providers should be aware of and provide guidance to patients regarding the identification of reliable online resources so that they can make informed decisions about DHS use for pain management.

背景患者越来越多地利用互联网来了解针对各种疾病/病症的饮食和草药补充剂(DHSs),包括疼痛管理。先前的研究发现,在线健康信息不一致且质量差,这可能对患者健康产生不利影响。这项研究评估了在线DHS消费者疼痛健康信息的质量。方法使用六个与DHSs和疼痛相关的搜索项目,在谷歌上生成四个英语国家的前20个网站。确定的480个网页产生了68个符合条件的网站,然后使用DISCERN工具对这些网站进行了评估。计算评审员对15个DISCERN工具项目的评分的平均分和标准差(SD),以及总体总分。结果68个符合条件的网站的平均总分为46.6(SD=10.1),平均总分为3.3(SD=0.8)。网站缺乏关于不确定性领域、未使用治疗的效果以及治疗如何影响整体生活质量的信息。这些缺点在商业网站中尤为明显,这些网站经常表现出偏见,未能报告国土安全部产品的风险,并且缺乏对国土安全部使用共享决策的支持。结论DHS用于疼痛的在线消费者健康信息的质量存在差异。医疗保健提供者应了解并指导患者识别可靠的在线资源,以便他们能够就DHS用于疼痛管理做出明智的决定。
{"title":"Dietary and herbal supplement consumer health information for pain: A cross-sectional survey and quality assessment of online content","authors":"Jeremy Y Ng,&nbsp;Sahar Popal,&nbsp;Sathurthika Selvanayagam","doi":"10.1016/j.imr.2023.100996","DOIUrl":"https://doi.org/10.1016/j.imr.2023.100996","url":null,"abstract":"<div><h3>Background</h3><p>Patients are increasingly utilizing the internet to learn about dietary and herbal supplements (DHSs) for various diseases/conditions, including pain management. Online health information has been found to be inconsistent and of poor quality in prior studies, which may have detrimental effects on patient health. This study assessed the quality of online DHSs consumer health information for pain.</p></div><div><h3>Methods</h3><p>Six search items related to DHSs and pain were used to generate the first 20 websites on Google across four English-speaking countries. The identified 480 webpages produced 68 eligible websites, which were then evaluated using the DISCERN tool. The mean scores and standard deviations (SD) of the reviewers’ ratings on each of the 15 DISCERN instrument items as well as the overall total score were calculated.</p></div><div><h3>Results</h3><p>The mean summed score for the 68 eligible websites was 46.6 (SD = 10.1), and the mean overall rating was 3.3 (SD = 0.8). Websites lacked information regarding areas of uncertainty, the effects of no treatment being used, and how treatments affect the overall quality of life. These shortcomings were especially apparent across commercial websites, which frequently displayed bias, failed to report the risks of DHS products, and lacked support for shared decision-making regarding the use of DHSs.</p></div><div><h3>Conclusion</h3><p>Variability exists in the quality of online consumer health information regarding DHS use for pain. Healthcare providers should be aware of and provide guidance to patients regarding the identification of reliable online resources so that they can make informed decisions about DHS use for pain management.</p></div>","PeriodicalId":13644,"journal":{"name":"Integrative Medicine Research","volume":null,"pages":null},"PeriodicalIF":3.4,"publicationDate":"2023-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49709228","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
What is integrative medicine? Establishing the decision criteria for an operational definition of integrative medicine for general practice health services research in Australia 什么是综合医学?制定澳大利亚全科医疗服务研究综合医学操作定义的决策标准
IF 3.4 4区 医学 Q1 Medicine Pub Date : 2023-09-24 DOI: 10.1016/j.imr.2023.100995
Jennifer Hunter , Joanna E. Harnett , Wai-Jo Jocelin Chan , Marie Pirotta

Background

Operational definitions outline how a conceptual definition will be measured for consistent, reproducible data collection and analysis. This article reports the decision criteria that will be used for an operational definition of integrative medicine (IM) in a secondary analysis of an Australian national survey of general practitioner activity.

Methods

A multidisciplinary team applied an iterative approach, informed by expert knowledge and literature reviews to establish decision criteria for categorizing the terms in the Australian clinical interface terminology of the International Classification of Primary Care, second edition (ICPC-2 PLUS) and the Coding Atlas for Pharmaceutical Substances, according to whether they reflected IM, conventional/mainstream medicine (MM), or both IM and MM (IM/MM).

Results

The final decision criteria categorized all terms for examinations, investigations, advice/counselling, and drugs with synthetic ingredients, and terms for referrals to secondary care services and healthcare practitioners that are not a traditional or complementary medicine practitioner as MM. Terms that could apply to both styles of clinical practice (e.g., preventive health, lifestyle medicine, psychosocial and some drugs with natural ingredients) were categorised as IM/MM. The remaining terms, that mostly reflected the World Health Organization's theoretical definitions of traditional and complementary medicine, were categorized as IM.

Conclusion

Differentiating between integrative and conventional/mainstream medicine in general practice is context specific and not always possible. The category IM/MM proposes integrative medicine as an extension, rather than an alternative. The rationale for the integrative medicine operational definition has relevance for researchers and health services in Australia, and internationally.

背景操作定义概述了如何衡量概念定义,以进行一致、可重复的数据收集和分析。本文报告了在对澳大利亚全国全科医生活动调查的二次分析中,将用于综合医学(IM)操作定义的决策标准。方法一个多学科团队在专家知识和文献综述的基础上,采用迭代方法,根据是否反映IM,建立对《国际初级保健分类》第二版(ICPC-2 PLUS)和《药物编码图谱》中的术语进行分类的决策标准,传统/主流医学(MM)或IM和MM两者(IM/MM)。结果最终决定标准将所有检查、调查、咨询/咨询和含有合成成分的药物的术语,以及转诊至二级护理服务和非传统或补充医学从业者的医疗从业者的术语归类为MM。适用于两种类型临床实践的术语(例如,预防性健康、生活方式医学、心理社会和一些含有天然成分的药物)被归类为IM/MM。其余术语主要反映了世界卫生组织对传统医学和补充医学的理论定义,被归类为IM。结论在全科医学中区分综合医学和传统/主流医学是特定的,并不总是可能的。IM/MM类别建议将综合医学作为一种延伸,而不是一种替代。综合医学操作定义的基本原理与澳大利亚和国际上的研究人员和卫生服务部门有关。
{"title":"What is integrative medicine? Establishing the decision criteria for an operational definition of integrative medicine for general practice health services research in Australia","authors":"Jennifer Hunter ,&nbsp;Joanna E. Harnett ,&nbsp;Wai-Jo Jocelin Chan ,&nbsp;Marie Pirotta","doi":"10.1016/j.imr.2023.100995","DOIUrl":"https://doi.org/10.1016/j.imr.2023.100995","url":null,"abstract":"<div><h3>Background</h3><p>Operational definitions outline how a conceptual definition will be measured for consistent, reproducible data collection and analysis. This article reports the decision criteria that will be used for an operational definition of integrative medicine (IM) in a secondary analysis of an Australian national survey of general practitioner activity.</p></div><div><h3>Methods</h3><p>A multidisciplinary team applied an iterative approach, informed by expert knowledge and literature reviews to establish decision criteria for categorizing the terms in the Australian clinical interface terminology of the International Classification of Primary Care, second edition (ICPC-2 PLUS) and the Coding Atlas for Pharmaceutical Substances, according to whether they reflected IM, conventional/mainstream medicine (MM), or both IM and MM (IM/MM).</p></div><div><h3>Results</h3><p>The final decision criteria categorized all terms for examinations, investigations, advice/counselling, and drugs with synthetic ingredients, and terms for referrals to secondary care services and healthcare practitioners that are not a traditional or complementary medicine practitioner as MM. Terms that could apply to both styles of clinical practice (e.g., preventive health, lifestyle medicine, psychosocial and some drugs with natural ingredients) were categorised as IM/MM. The remaining terms, that mostly reflected the World Health Organization's theoretical definitions of traditional and complementary medicine, were categorized as IM.</p></div><div><h3>Conclusion</h3><p>Differentiating between integrative and conventional/mainstream medicine in general practice is context specific and not always possible. The category IM/MM proposes integrative medicine as an extension, rather than an alternative. The rationale for the integrative medicine operational definition has relevance for researchers and health services in Australia, and internationally.</p></div>","PeriodicalId":13644,"journal":{"name":"Integrative Medicine Research","volume":null,"pages":null},"PeriodicalIF":3.4,"publicationDate":"2023-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49729391","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acupuncture treatment for functional gastrointestinal disorders: Identification of major acupoints using network analysis 针刺治疗功能性胃肠疾病:用网络分析识别主要穴位
IF 3.4 4区 医学 Q1 Medicine Pub Date : 2023-09-01 DOI: 10.1016/j.imr.2023.100970
Heeyoung Moon , Yeonhee Ryu , In-Seon Lee , Younbyoung Chae

Background

Using network analysis, we sought to determine the acupoints most commonly used to treat functional gastrointestinal disorders (FGIDs), particularly functional dyspepsia (FD) and irritable bowel syndrome (IBS).

Methods

To explore the acupoint patterns used for FGID, data on acupoint combinations for FD and IBS were gathered from systematic reviews. Network analysis was used to determine the degree, closeness centrality, betweenness centrality, and eigenvector centrality of each acupoint. The most common acupoint combinations for FD and IBS were examined based on the eigenvector centrality.

Results

Network analysis revealed that CV12, ST25, ST36, CV10, and LR3, which had the highest eigenvector centrality values, were the main acupoints for treating FGID. CV12 was the main acupoint for treating FD, while ST25 was the hub acupoint for treating IBS in the abdomen. ST36, LR3, and PC6 were the key peripheral acupoints for FD and IBS.

Conclusions

Using network analysis, we provided data that will aid the selection of both general and specific acupoints for FD and IBS, along with spatial information (i.e., the positions of acupoints on a body map). These findings could be applied in future acupuncture research on therapy for gastrointestinal system dysfunction. They may also help bridge the gap between the traditional meridian theory, which assumes that there is a link between diseases/symptoms and the specific body region being treated, and real-world clinical evidence.

背景采用网络分析法,我们试图确定最常用于治疗功能性胃肠道疾病(FGID)的穴位,特别是功能性消化不良(FD)和肠易激综合征(IBS)。采用网络分析法确定各穴位的程度、接近中心性、介数中心性和特征向量中心性。根据特征向量中心性检查FD和IBS最常见的穴位组合。结果网络分析显示,CV12、ST25、ST36、CV10和LR3是治疗FGID的主要穴位,其特征向量中心值最高。CV12为治疗FD的主要穴位,ST25为治疗腹部IBS的中枢穴位。ST36、LR3和PC6是FD和IBS的关键外周穴位。结论通过网络分析,我们提供了有助于选择FD和IBS的一般和特定穴位的数据,以及空间信息(即穴位在身体图上的位置)。这些发现可应用于未来针灸治疗胃肠系统功能障碍的研究。它们还可能有助于弥合传统经络理论与现实世界临床证据之间的差距,传统经络理论假设疾病/症状与正在治疗的特定身体区域之间存在联系。
{"title":"Acupuncture treatment for functional gastrointestinal disorders: Identification of major acupoints using network analysis","authors":"Heeyoung Moon ,&nbsp;Yeonhee Ryu ,&nbsp;In-Seon Lee ,&nbsp;Younbyoung Chae","doi":"10.1016/j.imr.2023.100970","DOIUrl":"10.1016/j.imr.2023.100970","url":null,"abstract":"<div><h3>Background</h3><p>Using network analysis, we sought to determine the acupoints most commonly used to treat functional gastrointestinal disorders (FGIDs), particularly functional dyspepsia (FD) and irritable bowel syndrome (IBS).</p></div><div><h3>Methods</h3><p>To explore the acupoint patterns used for FGID, data on acupoint combinations for FD and IBS were gathered from systematic reviews. Network analysis was used to determine the degree, closeness centrality, betweenness centrality, and eigenvector centrality of each acupoint. The most common acupoint combinations for FD and IBS were examined based on the eigenvector centrality.</p></div><div><h3>Results</h3><p>Network analysis revealed that CV12, ST25, ST36, CV10, and LR3, which had the highest eigenvector centrality values, were the main acupoints for treating FGID. CV12 was the main acupoint for treating FD, while ST25 was the hub acupoint for treating IBS in the abdomen. ST36, LR3, and PC6 were the key peripheral acupoints for FD and IBS.</p></div><div><h3>Conclusions</h3><p>Using network analysis, we provided data that will aid the selection of both general and specific acupoints for FD and IBS, along with spatial information (i.e., the positions of acupoints on a body map). These findings could be applied in future acupuncture research on therapy for gastrointestinal system dysfunction. They may also help bridge the gap between the traditional meridian theory, which assumes that there is a link between diseases/symptoms and the specific body region being treated, and real-world clinical evidence.</p></div>","PeriodicalId":13644,"journal":{"name":"Integrative Medicine Research","volume":null,"pages":null},"PeriodicalIF":3.4,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/18/a1/main.PMC10407428.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10026930","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Moxibustion for medical personnel with negative emotion and insomnia during COVID-19 pandemic: A randomized, controlled trial 艾灸对新冠肺炎大流行期间消极情绪和失眠医务人员的影响:一项随机对照试验
IF 3.4 4区 医学 Q1 Medicine Pub Date : 2023-09-01 DOI: 10.1016/j.imr.2023.100974
Xiying Li , Xiaojuan Li , Xian Wang , Xuan Yin , Shanshan Li , Junyi Wu , Xiumei Ren , Wei Zhang , Yiqun Mi , Shifen Xu

Background

We conducted this randomized controlled trial (RCT) to evaluate the effectiveness and safety of moxibustion at Sanyinjiao (SP6) acupoint for treatment of negative mood and sleep quality in healthcare workers during the 2019 coronavirus disease (COVID-19).

Methods

A total of 180 participants were divided in a 1:1 ratio into two groups, the treatment group (for moxibustion) and the control group (for no treatment). The treatment group had a 30-minute moxibustion therapy once a day for two weeks, followed by a two-week follow-up. The Hamilton Anxiety Scale (HAMA) was used to assess the degree of the participants' anxiety, and the Patient Health Questionnaire-9 (PHQ-9) was utilized to examine their depressed condition. The Maslach Burnout Inventory-General Survey (MBI-GS) was used to measure the level of burnout among healthcare workers. To determine the severity of insomnia, the Sleep Dysfunction Rating Scale (SDRS) was utilized. At baseline, week 2, and week 4, all scales were evaluated.

Results

Compared to the control group, the treatment group improved more significantly in the HAMA at week 2 (MD = -19.01, 95% CI: -21.89 to -16.14; P<0.001) and at week 4 follow-up visits (MD = -8.96, 95% CI: -11.19 to -6.73; P<0.001). A subgroup study of HAMA scores revealed that position and education had significant impact on treatment effectiveness. During the 2-week intervention period, the treatment group showed more significant improvements in depressive symptoms measured by PHQ-9 (13.00±2.41 vs. 15.60±3.65; P<0.001), work burnout symptoms measured by MBI-GS (MD = -11.88, 95% CI, -15.73 to -8.03; P<0.001), and insomnia symptoms measured by SDRS (MD = -2.45, 95% CI, -4.24 to -0.66; P<0.01). There were no significant adverse effects reported.

Conclusion

Moxibustion at SP6 may be an effective treatment to improve anxiety, depression, sleep quality, and quality of life for healthcare workers during COVID-19.

Trial registration

This trial was registered at Chinese Clinical Trial Registry (ChiCTR): ChiCTR-2200059327.

背景我们进行了随机对照试验(RCT),以评估艾灸三阴交穴治疗2019冠状病毒病(新冠肺炎)期间医护人员负面情绪和睡眠质量的有效性和安全性。方法将180名受试者按1:1的比例分为两组,治疗组(艾灸)和对照组(不治疗)。治疗组采用30分钟艾灸疗法,每天一次,持续两周,随后进行为期两周的随访。汉密尔顿焦虑量表(HAMA)用于评估参与者的焦虑程度,患者健康问卷-9(PHQ-9)用于检查他们的抑郁状况。Maslach倦怠量表综合调查(MBI-GS)用于衡量医护人员的倦怠水平。为了确定失眠的严重程度,使用了睡眠功能障碍评定量表(SDRS)。在基线、第2周和第4周,对所有量表进行评估。结果与对照组相比,治疗组在第2周的HAMA改善更为显著(MD=-19.01,95%CI:21.89至-16.14;P<;0.001),在第4周的随访中(MD=-8.96,95%CI:11.19至-6.73;P<:0.001)。HAMA评分的亚组研究显示,职位和教育对治疗效果有显著影响。在2周的干预期内,治疗组在PHQ-9测量的抑郁症状(13.00±2.41 vs.15.60±3.65;P<;0.001)、MBI-GS测量的工作倦怠症状(MD=-11.88,95%CI,-15.73至-8.03;P<)、,通过SDRS测量失眠症状(MD=2.45,95%CI-4.24--0.66;P<;0.01)。没有显著的不良反应报告。结论艾灸SP6可能是改善COVID-19期间医护人员焦虑、抑郁、睡眠质量和生活质量的有效治疗方法。
{"title":"Moxibustion for medical personnel with negative emotion and insomnia during COVID-19 pandemic: A randomized, controlled trial","authors":"Xiying Li ,&nbsp;Xiaojuan Li ,&nbsp;Xian Wang ,&nbsp;Xuan Yin ,&nbsp;Shanshan Li ,&nbsp;Junyi Wu ,&nbsp;Xiumei Ren ,&nbsp;Wei Zhang ,&nbsp;Yiqun Mi ,&nbsp;Shifen Xu","doi":"10.1016/j.imr.2023.100974","DOIUrl":"10.1016/j.imr.2023.100974","url":null,"abstract":"<div><h3>Background</h3><p>We conducted this randomized controlled trial (RCT) to evaluate the effectiveness and safety of moxibustion at Sanyinjiao (SP6) acupoint for treatment of negative mood and sleep quality in healthcare workers during the 2019 coronavirus disease (COVID-19).</p></div><div><h3>Methods</h3><p>A total of 180 participants were divided in a 1:1 ratio into two groups, the treatment group (for moxibustion) and the control group (for no treatment). The treatment group had a 30-minute moxibustion therapy once a day for two weeks, followed by a two-week follow-up. The Hamilton Anxiety Scale (HAMA) was used to assess the degree of the participants' anxiety, and the Patient Health Questionnaire-9 (PHQ-9) was utilized to examine their depressed condition. The Maslach Burnout Inventory-General Survey (MBI-GS) was used to measure the level of burnout among healthcare workers. To determine the severity of insomnia, the Sleep Dysfunction Rating Scale (SDRS) was utilized. At baseline, week 2, and week 4, all scales were evaluated.</p></div><div><h3>Results</h3><p>Compared to the control group, the treatment group improved more significantly in the HAMA at week 2 (MD = -19.01, 95% CI: -21.89 to -16.14; <em>P</em>&lt;0.001) and at week 4 follow-up visits (MD = -8.96, 95% CI: -11.19 to -6.73; <em>P</em>&lt;0.001). A subgroup study of HAMA scores revealed that position and education had significant impact on treatment effectiveness. During the 2-week intervention period, the treatment group showed more significant improvements in depressive symptoms measured by PHQ-9 (13.00±2.41 vs. 15.60±3.65; <em>P</em>&lt;0.001), work burnout symptoms measured by MBI-GS (MD = -11.88, 95% CI, -15.73 to -8.03; <em>P</em>&lt;0.001), and insomnia symptoms measured by SDRS (MD = -2.45, 95% CI, -4.24 to -0.66; <em>P</em>&lt;0.01). There were no significant adverse effects reported.</p></div><div><h3>Conclusion</h3><p>Moxibustion at SP6 may be an effective treatment to improve anxiety, depression, sleep quality, and quality of life for healthcare workers during COVID-19.</p></div><div><h3>Trial registration</h3><p>This trial was registered at Chinese Clinical Trial Registry (ChiCTR): ChiCTR-2200059327.</p></div>","PeriodicalId":13644,"journal":{"name":"Integrative Medicine Research","volume":null,"pages":null},"PeriodicalIF":3.4,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/44/9a/main.PMC10448013.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10464641","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Curcumin, inflammation, and neurological disorders: How are they linked? 姜黄素、炎症和神经系统疾病:它们是如何联系在一起的?
IF 3.4 4区 医学 Q1 Medicine Pub Date : 2023-09-01 DOI: 10.1016/j.imr.2023.100968
Prachi Garodia , Mangala Hegde , Ajaikumar B. Kunnumakkara , Bharat B. Aggarwal

Background

Despite the extensive research in recent years, the current treatment modalities for neurological disorders are suboptimal. Curcumin, a polyphenol found in Curcuma genus, has been shown to mitigate the pathophysiology and clinical sequalae involved in neuroinflammation and neurodegenerative diseases.

Methods

We searched PubMed database for relevant publications on curcumin and its uses in treating neurological diseases. We also reviewed relevant clinical trials which appeared on searching PubMed database using ‘Curcumin and clinical trials’.

Results

This review details the pleiotropic immunomodulatory functions and neuroprotective properties of curcumin, its derivatives and formulations in various preclinical and clinical investigations. The effects of curcumin on neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), brain tumors, epilepsy, Huntington's disorder (HD), ischemia, Parkinson's disease (PD), multiple sclerosis (MS), and traumatic brain injury (TBI) with a major focus on associated signalling pathways have been thoroughly discussed.

Conclusion

This review demonstrates curcumin can suppress spinal neuroinflammation by modulating diverse astroglia mediated cascades, ensuring the treatment of neurological disorders.

背景尽管近年来进行了广泛的研究,但目前神经系统疾病的治疗方式并不理想。姜黄素是一种在姜黄属中发现的多酚,已被证明可以减轻神经炎症和神经退行性疾病的病理生理学和临床后果。方法检索PubMed数据库中有关姜黄素及其在神经系统疾病治疗中的应用的相关文献。我们还回顾了PubMed数据库中使用“姜黄素和临床试验”搜索的相关临床试验。结果综述了姜黄素及其衍生物和制剂在各种临床前和临床研究中的多效性免疫调节功能和神经保护特性。姜黄素对神经退行性疾病的影响,如阿尔茨海默病(AD)、肌萎缩性侧索硬化症(ALS)、脑肿瘤、癫痫、亨廷顿舞蹈症(HD)、缺血、帕金森病(PD)、多发性硬化症(MS)和创伤性脑损伤(TBI),主要关注相关的信号通路,已经进行了深入的讨论。结论姜黄素可以通过调节星形胶质细胞介导的多种级联反应来抑制脊髓神经炎症,确保神经系统疾病的治疗。
{"title":"Curcumin, inflammation, and neurological disorders: How are they linked?","authors":"Prachi Garodia ,&nbsp;Mangala Hegde ,&nbsp;Ajaikumar B. Kunnumakkara ,&nbsp;Bharat B. Aggarwal","doi":"10.1016/j.imr.2023.100968","DOIUrl":"10.1016/j.imr.2023.100968","url":null,"abstract":"<div><h3>Background</h3><p>Despite the extensive research in recent years, the current treatment modalities for neurological disorders are suboptimal. Curcumin, a polyphenol found in <em>Curcuma</em> genus, has been shown to mitigate the pathophysiology and clinical sequalae involved in neuroinflammation and neurodegenerative diseases.</p></div><div><h3>Methods</h3><p>We searched PubMed database for relevant publications on curcumin and its uses in treating neurological diseases. We also reviewed relevant clinical trials which appeared on searching PubMed database using ‘Curcumin and clinical trials’.</p></div><div><h3>Results</h3><p>This review details the pleiotropic immunomodulatory functions and neuroprotective properties of curcumin, its derivatives and formulations in various preclinical and clinical investigations. The effects of curcumin on neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), brain tumors, epilepsy, Huntington's disorder (HD), ischemia, Parkinson's disease (PD), multiple sclerosis (MS), and traumatic brain injury (TBI) with a major focus on associated signalling pathways have been thoroughly discussed.</p></div><div><h3>Conclusion</h3><p>This review demonstrates curcumin can suppress spinal neuroinflammation by modulating diverse astroglia mediated cascades, ensuring the treatment of neurological disorders.</p></div>","PeriodicalId":13644,"journal":{"name":"Integrative Medicine Research","volume":null,"pages":null},"PeriodicalIF":3.4,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/83/fd/main.PMC10469086.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10152438","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Patient preferences and shared decision making for the traditional Chinese medicine treatment of lung cancer: A discrete choice experiment study 肺癌中医治疗的患者偏好与共同决策:离散选择实验研究
IF 3.4 4区 医学 Q1 Medicine Pub Date : 2023-09-01 DOI: 10.1016/j.imr.2023.100969
Yue Teng , Yan Wei , Yingyao Chen , Juntao Yan , Shimeng Liu , Fuming Li , Shiyi Bao , Yanfeng Ren , Liu Liu , Yi Yang

Background

Traditional Chinese Medicine (TCM), integrating patient preferences into decision-making process, has been widely used in the multimodality therapy of lung cancer. This study aimed to estimate patient preferences for treatment and shared decision-making (SDM) modes concerning inpatient TCM treatment of lung cancer in Shanghai in order to provide a basis for clinical decision-making process on TCM therapy for lung cancer.

Methods

This study was conducted among patients (n = 347) from nine tertiary hospitals in Shanghai by discrete-choice experiment (DCE) survey and Shared Decision-Making Questionnaire-patient version (SDM-Q-9) survey. The DCE was developed with the inclusion of the most relevant attributes at appropriate levels for the TCM treatment of lung cancer. The empirical data analyses of patients were performed using mixed logit models. Additionally, subgroup analysis was conducted.

Results

In total, 347 respondents completed the questionnaire. All attributes’ coefficients were statistically significant for patients’ preferences. Patients showed strong preferences for increasing disease control rate, relieving nausea and vomiting, reducing the risk of side effects, and were concerned about monthly out-of-pocket costs. Subgroup analysis indicated that patients with a lower SDM-Q-9 score and those who were satisfied with medical services emphasized more importance of higher disease control rate. Furthermore, most of the patients (90.20%) self-reported a high willingness to use SDM during the decision-making process.

Conclusion

In Shanghai, patients mainly preferred SDM and considered disease control rate as the most essential attribute in the TCM treatment of lung cancer. The study findings could underscore the importance of considering patients’ preferences and promote SDM.

背景中医将患者的喜好融入决策过程,已广泛应用于癌症的多模式治疗。本研究旨在评估上海市癌症住院中医治疗的患者治疗偏好和共享决策模式,为癌症中医治疗的临床决策过程提供依据。方法采用离散选择实验(DCE)和共享决策问卷(SDM-Q-9)两种方法对上海市9所三甲医院347名患者进行问卷调查。DCE的开发包含了在适当水平上对癌症的中医治疗最相关的属性。使用混合logit模型对患者进行实证数据分析。此外,还进行了亚组分析。结果共有347名被调查者完成了问卷调查。所有属性的系数对患者的偏好具有统计学意义。患者对提高疾病控制率、缓解恶心和呕吐、降低副作用风险表现出强烈的偏好,并担心每月的自付费用。亚组分析表明,SDM-Q-9评分较低的患者和对医疗服务满意的患者更强调疾病控制率较高的重要性。此外,大多数患者(90.20%)自我报告在决策过程中使用SDM的意愿很高。结论上海地区患者以SDM为主,疾病控制率是癌症中医治疗最基本的指标。研究结果可以强调考虑患者偏好和促进SDM的重要性。
{"title":"Patient preferences and shared decision making for the traditional Chinese medicine treatment of lung cancer: A discrete choice experiment study","authors":"Yue Teng ,&nbsp;Yan Wei ,&nbsp;Yingyao Chen ,&nbsp;Juntao Yan ,&nbsp;Shimeng Liu ,&nbsp;Fuming Li ,&nbsp;Shiyi Bao ,&nbsp;Yanfeng Ren ,&nbsp;Liu Liu ,&nbsp;Yi Yang","doi":"10.1016/j.imr.2023.100969","DOIUrl":"10.1016/j.imr.2023.100969","url":null,"abstract":"<div><h3>Background</h3><p>Traditional Chinese Medicine (TCM), integrating patient preferences into decision-making process, has been widely used in the multimodality therapy of lung cancer. This study aimed to estimate patient preferences for treatment and shared decision-making (SDM) modes concerning inpatient TCM treatment of lung cancer in Shanghai in order to provide a basis for clinical decision-making process on TCM therapy for lung cancer.</p></div><div><h3>Methods</h3><p>This study was conducted among patients (<em>n</em> = 347) from nine tertiary hospitals in Shanghai by discrete-choice experiment (DCE) survey and Shared Decision-Making Questionnaire-patient version (SDM-Q-9) survey. The DCE was developed with the inclusion of the most relevant attributes at appropriate levels for the TCM treatment of lung cancer. The empirical data analyses of patients were performed using mixed logit models. Additionally, subgroup analysis was conducted.</p></div><div><h3>Results</h3><p>In total, 347 respondents completed the questionnaire. All attributes’ coefficients were statistically significant for patients’ preferences. Patients showed strong preferences for increasing disease control rate, relieving nausea and vomiting, reducing the risk of side effects, and were concerned about monthly out-of-pocket costs. Subgroup analysis indicated that patients with a lower SDM-Q-9 score and those who were satisfied with medical services emphasized more importance of higher disease control rate. Furthermore, most of the patients (90.20%) self-reported a high willingness to use SDM during the decision-making process.</p></div><div><h3>Conclusion</h3><p>In Shanghai, patients mainly preferred SDM and considered disease control rate as the most essential attribute in the TCM treatment of lung cancer. The study findings could underscore the importance of considering patients’ preferences and promote SDM.</p></div>","PeriodicalId":13644,"journal":{"name":"Integrative Medicine Research","volume":null,"pages":null},"PeriodicalIF":3.4,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/5f/f2/main.PMC10400851.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10308768","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acupuncture as an alternative or in addition to conventional treatment for chronic non-specific low back pain: A systematic review and meta-analysis 针灸作为慢性非特异性腰痛常规治疗的替代或补充:一项系统综述和荟萃分析。
IF 3.4 4区 医学 Q1 Medicine Pub Date : 2023-09-01 DOI: 10.1016/j.imr.2023.100972
Carlo Maria Giovanardi , Marien Gonzalez-Lorenzo , Alessandra Poini , Eleonora Marchi , Antonio Culcasi , Francesco Ursini , Cesare Faldini , Alberto Di Martino , Umberto Mazzanti , Emanuela Campesato , Annunzio Matrà , Sabina Cevoli , Maria Grazia Benedetti

Background

Conventional therapies (CTs), pharmacological (PH) and non–pharmacological (NPH), do not always achieve benefits in the treatment of chronic low back pain (CLBP). We assessed efficacy and safety of acupuncture for CLBP as alternative or addition to CT.

Methods

We included randomised controlled trials (RCTs) comparing acupuncture alone or in combination with CT to CT. We searched Medline, Cochrane Library, Embase up to May 2022. We assessed risk of bias with the original Cochrane tool and GRADE certainty of evidence. Results were pooled through meta-analysis.

Results

Ten RCTs (2122 participants) were included comparing acupuncture versus CT and 4 RCTs (374 participants) were comparing acupuncture plus CT to CT alone. In terms of comparing acupuncture with NPH or PH, no differences were found for pain and disability. Comparing acupuncture with PH and NPH combined, pain and disability were reduced (SMD=-0.50, 95% CI -0.62 to -0.37; SMD=-0.71, 95% CI -1.17 to -0.24). Comparing acupuncture plus NPH with NPH alone, pain and disability were reduced (SMD=-0.70, 95% CI -0.94 to -0.46; SMD=-0.95, 95% CI -1.36 to -0.54). Comparing acupuncture plus PH with PH alone, pain and disability were reduced (MD=-0.21, 95% CI -433.28 to -10.42; MD=-3.1, 95% CI -4.87 to -1.83). Comparing acupuncture plus combined treatment versus combined treatment alone, no differences were found in pain, while disability was reduced (MD=-3.40 95% CI -5.17 to -1.63). No studies assessed adverse event. Certainty of evidence ranged from moderate to very low.

Conclusions

We are uncertain whether acupuncture is more effective and safer than CT. In the comparisons without estimates’ imprecision, acupuncture showed promising results. Acupuncture could be an option based on patients’ preferences.

背景:常规疗法(CT)、药理学(PH)和非药理学(NPH)在治疗慢性腰痛(CLBP)方面并不总是有效。我们评估了针灸作为CT的替代或补充治疗CLBP的疗效和安全性。方法:我们纳入了随机对照试验(RCT),将单独或联合针灸与CT进行比较。我们搜索了Medline、Cochrane Library、Embase,直到2022年5月。我们使用原始的Cochrane工具和GRADE证据确定性评估了偏倚的风险。结果:10项随机对照试验(2122名参与者)比较了针灸与CT,4项随机对照研究(374名参与者)将针灸加CT与单独CT进行了比较。就针灸与NPH或PH的比较而言,在疼痛和残疾方面没有发现差异。针刺与PH和NPH联合治疗相比,疼痛和残疾减轻(SMD=-0.50,95%CI-0.62至-0.37;SMD=-0.71,95%CI-1.17至-0.24)。针刺与NPH联合用药与单独用药相比,痛苦和残疾减轻了(SMD=-0.70,95%CI-0.94至-0.46;SMD=-0.55,95%CI-1.36至-0.54),疼痛和残疾减轻(MD=-0.21,95%CI-433.28至-10.42;MD=-3.1,95%CI-4.87至-1.83)。比较针灸联合治疗和单独联合治疗,疼痛没有差异,残疾减轻(MD=-3.40,95%CI-5.17至-1.63)。没有研究评估不良事件。证据的确定性从中等到极低不等。结论:我们不确定针灸是否比CT更有效、更安全。在没有估计不精确的比较中,针灸显示出有希望的结果。针灸可以根据患者的喜好进行选择。
{"title":"Acupuncture as an alternative or in addition to conventional treatment for chronic non-specific low back pain: A systematic review and meta-analysis","authors":"Carlo Maria Giovanardi ,&nbsp;Marien Gonzalez-Lorenzo ,&nbsp;Alessandra Poini ,&nbsp;Eleonora Marchi ,&nbsp;Antonio Culcasi ,&nbsp;Francesco Ursini ,&nbsp;Cesare Faldini ,&nbsp;Alberto Di Martino ,&nbsp;Umberto Mazzanti ,&nbsp;Emanuela Campesato ,&nbsp;Annunzio Matrà ,&nbsp;Sabina Cevoli ,&nbsp;Maria Grazia Benedetti","doi":"10.1016/j.imr.2023.100972","DOIUrl":"10.1016/j.imr.2023.100972","url":null,"abstract":"<div><h3>Background</h3><p>Conventional therapies (CTs), pharmacological (PH) and non–pharmacological (NPH), do not always achieve benefits in the treatment of chronic low back pain (CLBP). We assessed efficacy and safety of acupuncture for CLBP as alternative or addition to CT.</p></div><div><h3>Methods</h3><p>We included randomised controlled trials (RCTs) comparing acupuncture alone or in combination with CT to CT. We searched Medline, Cochrane Library, Embase up to May 2022. We assessed risk of bias with the original Cochrane tool and GRADE certainty of evidence. Results were pooled through meta-analysis.</p></div><div><h3>Results</h3><p>Ten RCTs (2122 participants) were included comparing acupuncture versus CT and 4 RCTs (374 participants) were comparing acupuncture plus CT to CT alone. In terms of comparing acupuncture with NPH or PH, no differences were found for pain and disability. Comparing acupuncture with PH and NPH combined, pain and disability were reduced (SMD=-0.50, 95% CI -0.62 to -0.37; SMD=-0.71, 95% CI -1.17 to -0.24). Comparing acupuncture plus NPH with NPH alone, pain and disability were reduced (SMD=-0.70, 95% CI -0.94 to -0.46; SMD=-0.95, 95% CI -1.36 to -0.54). Comparing acupuncture plus PH with PH alone, pain and disability were reduced (MD=-0.21, 95% CI -433.28 to -10.42; MD=-3.1, 95% CI -4.87 to -1.83). Comparing acupuncture plus combined treatment versus combined treatment alone, no differences were found in pain, while disability was reduced (MD=-3.40 95% CI -5.17 to -1.63). No studies assessed adverse event. Certainty of evidence ranged from moderate to very low.</p></div><div><h3>Conclusions</h3><p>We are uncertain whether acupuncture is more effective and safer than CT. In the comparisons without estimates’ imprecision, acupuncture showed promising results. Acupuncture could be an option based on patients’ preferences.</p></div>","PeriodicalId":13644,"journal":{"name":"Integrative Medicine Research","volume":null,"pages":null},"PeriodicalIF":3.4,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/13/d0/main.PMC10448023.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10482866","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
Integrative Medicine Research
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1